Whitehawk Therapeutics (WHWK) Short Interest Ratio & Short Volume

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. WHWK shares currently have a short interest ratio of 3.8. Learn More on Whitehawk Therapeutics's short interest ratio.

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Whitehawk Therapeutics: Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.33% of Whitehawk Therapeutics' floating shares are currently sold short.

Whitehawk Therapeutics saw a increase in short interest in April. As of April 30th, there was short interest totaling 824,655 shares, an increase of 5.7% from the previous total of 780,056 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

3.33% of Whitehawk Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Whitehawk Therapeutics: Cullinan Therapeutics, Inc. (15.66%), ARS Pharmaceuticals, Inc. (39.84%), Kura Oncology, Inc. (18.81%), Alto Neuroscience, Inc. (5.60%), Relmada Therapeutics, Inc. (5.96%), Vor Biopharma Inc. (9.19%), BioAge Labs, Inc. (5.36%), MeiraGTx Holdings PLC (6.69%), Inventiva S.A. Sponsored ADR (0.65%), Tilray Brands, Inc. (16.80%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($86.09 billion), Invesco QQQ ($39.89 billion), iShares Russell 2000 ETF ($26.13 billion), Western Digital Corporation ($12.66 billion), Salesforce Inc. ($12.29 billion), Sandisk Corporation ($11.87 billion), SPDR S&P Biotech ETF ($9.82 billion), Lumentum Holdings Inc. ($8.51 billion), iShares 20+ Year Treasury Bond ETF ($7.76 billion), and Bloom Energy Corporation ($7.40 billion). View all of the most shorted stocks.

Short selling WHWK is an investing strategy that aims to generate trading profit from Whitehawk Therapeutics as its price is falling. WHWK shares are trading up $0.08 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Whitehawk Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of WHWK, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including WHWK, twice per month. The most recent reporting period available is April, 30 2026.